Novo Nordisk ' s controlling shareholder plans to invest up to $7 billion a year by 2030

Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, plans to invest up to $7 billion annually by 2030, the Financial Times reported on Monday. Kasim Kutay, chief executive of Novo Holdings, told the newspaper that income from its 28% stake in Novo Nordisk and other…#novoholdings #danish #novonordisk #kasimkutay #novo #catalent
Source: Reuters: Health - Category: Consumer Health News Source Type: news